Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures (Q33975979)

30 July 2017

title

Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures (English)

1 reference

30 July 2017

1 reference

12

Kanneboyina Nagaraju

1 reference

30 July 2017

Heather Gordish-Dressman

2

object named as

Heather Gordish-Dressman

1 reference

30 July 2017

11

Eric P Hoffman

1 reference

30 July 2017

author name string

Christopher F Spurney

1

1 reference

30 July 2017

Alfredo D Guerron

3

1 reference

30 July 2017

Arpana Sali

4

1 reference

30 July 2017

Gouri S Pandey

5

1 reference

30 July 2017

Rashmi Rawat

6

1 reference

30 July 2017

Jack H Van Der Meulen

7

1 reference

30 July 2017

Hee-Jae Cha

8

1 reference

30 July 2017

Emidio E Pistilli

9

1 reference

30 July 2017

Terence A Partridge

10

1 reference

30 July 2017

language of work or name

1 reference

1 May 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

39

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

591-602

1 reference

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Standardization and statistical approaches to therapeutic trials in the R6/2 mouse

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Mdx mouse as therapeutic model system: development and implementation of phenotypic monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Satellite cell numbers in young and older men 24 hours after eccentric exercise

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Nutritional therapy improves function and complements corticosteroid intervention in mdx mice

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Systemic administration of L-arginine benefits mdx skeletal muscle function

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Weekly oral prednisolone improves survival and strength in malemdx mice

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116326

Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings

29 October 2018

1 reference

12 December 2020

Functional regeneration in the hindlimb skeletal muscle of the mdx mouse

1 reference

12 December 2020

Pre-clinical screening of drugs using the mdx mouse

1 reference

12 December 2020

Strength and endurance in the therapeutic evaluation of prednisolone-treated MDX mice

1 reference

12 December 2020

Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice

1 reference

12 December 2020

Phenotype of dystrophinopathy in old MDX mice

1 reference

12 December 2020

Cromolyn increases strength in exercised mdx mice

1 reference

12 December 2020

Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle

1 reference

12 December 2020

Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse

1 reference

12 December 2020

Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice

1 reference

12 December 2020

Evidence ofmdx mouse skeletal muscle fragility in vivo by eccentric running exercise

1 reference

12 December 2020

First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant

1 reference

12 December 2020

Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice

1 reference

12 December 2020

Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice

1 reference

12 December 2020

Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice

1 reference

12 December 2020

Long-term administration of pirfenidone improves cardiac function in mdx mice

1 reference

12 December 2020

Identifiers

DOI

10.1002/MUS.21211

1 reference

30 July 2017

1 reference

30 July 2017

1 reference